CureVac N.V (NASDAQ:CVAC) shares, rose in value, with the stock price up by 4.28% to the previous day’s close as strong demand from buyers drove the stock to $4.63.
Actively observing the price movement in the last trading, the stock closed the session at $4.44. The PE ratio was 5.14 over 12-month period. Referring to stock’s 52-week performance, its high was $5.28, and the low was $2.37. On the whole, CVAC has fluctuated by 31.16% over the past month.
With the market capitalization of CureVac N.V currently standing at about $1.04 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.27M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVAC’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of CVAC currently trading nearly 22.54% and 38.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 70.57, while the 7-day volatility ratio is showing 3.37% which for the 30-day chart, stands at 5.09%. Furthermore, CureVac N.V (CVAC)’s beta value is 2.49, and its average true range (ATR) is 0.28.
A comparison of CureVac N.V (CVAC) with its peers suggests the former has fared considerably weaker in the market. CVAC showed an intraday change of 4.28% in last session, and over the past year, it grew by 25.47%%.
Data on historical trading for CureVac N.V (NASDAQ:CVAC) indicates that the trading volumes over the past 3 months, they’ve averaged 656.92K. According to company’s latest data on outstanding shares, there are 225.16 million shares outstanding.
Nearly 58.26% of CureVac N.V’s shares belong to company insiders and institutional investors own 4.26% of the company’s shares. The stock has risen by 35.78% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVAC stock heading into the next quarter.
